Bank of New York Mellon’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
736,368
+22,014
+3% +$212K ﹤0.01% 1983
2026
Q1
$5.3M Sell
714,354
-25,663
-3% -$270K ﹤0.01% 2281
2025
Q4
$8.7M Sell
740,017
-25,789
-3% -$278K ﹤0.01% 2004
2025
Q3
$5.91M Sell
765,806
-17,293
-2% -$121K ﹤0.01% 2224
2025
Q2
$5.72M Sell
783,099
-14,265
-2% -$115K ﹤0.01% 2192
2025
Q1
$7.57M Sell
797,364
-52,388
-6% -$654K ﹤0.01% 2001
2024
Q4
$14M Buy
849,752
+15,269
+2% +$237K ﹤0.01% 1747
2024
Q3
$12.3M Sell
834,483
-119,392
-13% -$1.87M ﹤0.01% 1823
2024
Q2
$13.2M Buy
953,875
+16,023
+2% +$227K ﹤0.01% 1813
2024
Q1
$14.7M Sell
937,852
-49,251
-5% -$760K ﹤0.01% 1747
2023
Q4
$16M Sell
987,103
-761
-0.1% -$12.5K ﹤0.01% 1710
2023
Q3
$12.2M Sell
987,864
-42,884
-4% -$638K ﹤0.01% 1825
2023
Q2
$16.6M Sell
1,030,748
-30,492
-3% -$502K ﹤0.01% 1656
2023
Q1
$18.5M Sell
1,061,240
-16,542
-2% -$236K ﹤0.01% 1588
2022
Q4
$9.96M Sell
1,077,782
-25,799
-2% -$241K ﹤0.01% 1946
2022
Q3
$9.5M Buy
1,103,581
+50,410
+5% +$501K ﹤0.01% 1927
2022
Q2
$8.58M Sell
1,053,171
-132,038
-11% -$1.26M ﹤0.01% 2033
2022
Q1
$14.4M Sell
1,185,209
-204,280
-15% -$4.3M ﹤0.01% 1871
2021
Q4
$47.4M Sell
1,389,489
-28,747
-2% -$1.13M 0.01% 1210
2021
Q3
$68.4M Buy
1,418,236
+27,579
+2% +$1.28M 0.01% 914
2021
Q2
$62.8M Sell
1,390,657
-17,515
-1% -$776K 0.01% 988
2021
Q1
$67.9M Sell
1,408,172
-1,867
-0.1% -$97.2K 0.01% 907
2020
Q4
$75.9M Buy
1,410,039
+2,183
+0.2% +$98.6K 0.02% 788
2020
Q3
$51.9M Sell
1,407,856
-12,126
-0.9% -$451K 0.01% 892
2020
Q2
$44M Sell
1,419,982
-40,578
-3% -$1.12M 0.01% 958
2020
Q1
$40.3M Sell
1,460,560
-70,365
-5% -$2.11M 0.01% 867
2019
Q4
$44.8M Buy
1,530,925
+41,201
+3% +$981K 0.01% 1054
2019
Q3
$28.5M Sell
1,489,724
-47,761
-3% -$1.12M 0.01% 1306
2019
Q2
$33.7M Sell
1,537,485
-292,755
-16% -$6.42M 0.01% 1222
2019
Q1
$37.4M Buy
1,830,240
+1,047,450
+134% +$18.2M 0.01% 1148
2018
Q4
$9.87M Sell
782,790
-99,454
-11% -$1.48M ﹤0.01% 1906
2018
Q3
$13.5M Buy
882,244
+182,172
+26% +$2.52M ﹤0.01% 1859
2018
Q2
$9.18M Sell
700,072
-3,440
-0.5% -$37.9K ﹤0.01% 2064
2018
Q1
$5.74M Sell
703,512
-114,684
-14% -$929K ﹤0.01% 2279
2017
Q4
$7.25M Sell
818,196
-164,364
-17% -$1.52M ﹤0.01% 2162
2017
Q3
$10.9M Buy
982,560
+38,776
+4% +$377K ﹤0.01% 1948
2017
Q2
$8.46M Buy
943,784
+160,773
+21% +$1.28M ﹤0.01% 2068
2017
Q1
$6.18M Sell
783,011
-78,709
-9% -$641K ﹤0.01% 2222
2016
Q4
$7.38M Sell
861,720
-36,104
-4% -$309K ﹤0.01% 2123
2016
Q3
$7.38M Buy
897,824
+87,657
+11% +$735K ﹤0.01% 2029
2016
Q2
$6.51M Buy
810,167
+435,806
+116% +$3.49M ﹤0.01% 2073
2016
Q1
$2.52M Buy
374,361
+50,731
+16% +$334K ﹤0.01% 2530
2015
Q4
$2.55M Buy
323,630
+162,330
+101% +$1.19M ﹤0.01% 2570
2015
Q3
$925K Sell
161,300
-81,305
-34% -$503K ﹤0.01% 3232
2015
Q2
$1.31M Buy
242,605
+153,761
+173% +$793K ﹤0.01% 3184
2015
Q1
$415K Sell
88,844
-7,072
-7% -$30.7K ﹤0.01% 3684
2014
Q4
$400K Sell
95,916
-14,411
-13% -$66.2K ﹤0.01% 3701
2014
Q3
$575K Buy
110,327
+76,753
+229% +$394K ﹤0.01% 3570
2014
Q2
$111K Sell
33,574
-95,272
-74% -$317K ﹤0.01% 3974
2014
Q1
$447K Sell
128,846
-1,447
-1% -$5.42K ﹤0.01% 3616
2013
Q4
$472K Buy
130,293
+31,428
+32% +$109K ﹤0.01% 3597
2013
Q3
$297K Sell
98,865
-326
-0.3% -$919 ﹤0.01% 3684
2013
Q2
$394K Buy
+99,191
New +$378K ﹤0.01% 3579

Other funds holding NEO

Bank of New York Mellon's NEO Position: Q2 2026 in Review

Bank of New York Mellon increased its NeoGenomics (NEO) stake by 3.1% in Q2 2026, buying an estimated $212K and bringing the position to 736,368 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Bank of New York Mellon first reported a position in NEO in Q2 2013 and has held it in 53 quarters since. The position peaked at $75.9M in Q4 2020. 128 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Bank of New York Mellon held 736,368 shares of NeoGenomics worth $10.7M as of Q2 2026.
  • Bank of New York Mellon bought 22,014 NeoGenomics shares in Q2 2026, an estimated $212K.
  • NeoGenomics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1983 holding.
  • Bank of New York Mellon first reported a position in NeoGenomics in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's NeoGenomics position peaked at $75.9M in Q4 2020.
  • 128 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.